AHR and glioma: It has been shown on glioma cell lines that AhR promotes the development of a malignant phenotype of glioma cells at the level of proliferation, clonogenicity, and invasiveness: these properties weaken during exposure to a low-molecular-weight inhibitor of AhR (CH-223191) or after an AhR knockout.